BamSEC and AlphaSense Join Forces
Learn More

CAMP4 Therapeutics Corporation – Material Contracts

NASDAQ: CAMP    
Share price (3/27/26): $4.31    
Market cap (3/27/26): $224 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.22
from 10-K 3 pages CAMP4 Therapeutics Corporation Inducement Option Award Agreement
12/34/56
EX-10.21
from 10-K 50 pages Lease Agreement
12/34/56
EX-10.20
from 10-K 82 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Company if Publicly Disclosed Research, Collaboration and License Agreement by and Between CAMP4 Therapeutics Corporation and Glaxosmithkline Intellectual Property (No. 3) Limited Dated as of December 17, 2025
12/34/56
EX-10.15
from 10-K 5 pages First Amendment to Lease
12/34/56
EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 48 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 2 pages CAMP4 Therapeutics Corporation Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.16
from S-1/A 5 pages Camp4 Therapeutics Corporation Policy for Recoupment of Incentive Compensation
12/34/56
EX-10.13
from S-1/A 2 pages Camp4 Therapeutics Corporation Non-Employee Director Compensation Policy
12/34/56
EX-10.12
from S-1/A 10 pages Camp4 Therapeutics Corporation Severance and Change in Control Plan
12/34/56
EX-10.10
from S-1/A 10 pages Camp4 Therapeutics Corporation 2024 Employee Stock Purchase Plan
12/34/56
EX-10.9
from S-1/A 10 pages Camp4 Therapeutics Corporation Amended and Restated Employment Agreement
12/34/56
EX-10.8
from S-1/A 4 pages Camp4 Therapeutics Corporation 2024 Equity Incentive Plan Non-Statutory Stock Option Agreement
12/34/56
EX-10.7
from S-1/A 4 pages Camp4 Therapeutics Corporation 2024 Equity Incentive Plan Incentive Stock Option Agreement
12/34/56
EX-10.6
from S-1/A 3 pages Camp4 Therapeutics Corporation 2024 Equity Incentive Plan Non-Statutory Stock Option Agreement
12/34/56
EX-10.5
from S-1/A 16 pages Camp4 Therapeutics Corporation 2024 Equity Incentive Plan
12/34/56
EX-10.11
from S-1/A 14 pages Indemnification Agreement
12/34/56
EX-10.15
from S-1 87 pages Summary of Basic Lease Information
12/34/56
EX-10.14
from S-1 54 pages Lease Agreement
12/34/56
EX-10.4
from S-1 34 pages Camp4 Therapeutics Corporation Amended and Restated 2016 Stock Option and Grant Plan
12/34/56